Gene · 7026
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiple roles and regulatory mechanisms of the transcription factor HNF4 in the intestine. | Front Endocrinol (Lausanne) | 2023 | 37635981 | PubTator, text mining | PubMed |
| Generation of Human Endometrial Assembloids with a Luminal Epithelium using Air-Liquid Interface Culture Methods. | Adv Sci (Weinh) | 2023 | 37635169 | PubTator, text mining | PubMed |
| Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer. | Biomedicines | 2023 | 37626731 | PubTator, text mining | PubMed |
| Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma. | Invest Ophthalmol Vis Sci | 2023 | 37603355 | PubTator, text mining | PubMed |
| Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review. | Int J Mol Sci | 2023 | 37569402 | PubTator, text mining | PubMed |
| A genome-wide by PM10 exposure interaction study for blood pressure in Korean adults. | Sci Rep | 2023 | 37567956 | PubTator, text mining | PubMed |
| Direct differentiation of human pluripotent stem cells into vascular network along with supporting mural cells. | APL Bioeng | 2023 | 37564277 | PubTator, text mining | PubMed |
| Cross-species transcriptomics reveals bifurcation point during the arterial-to-hemogenic transition. | Commun Biol | 2023 | 37558796 | PubTator, text mining | PubMed |
| Ramifications of POU4F3 variants associated with autosomal dominant hearing loss in various molecular aspects. | Sci Rep | 2023 | 37537203 | PubTator, text mining | PubMed |
| Prox1 Suppresses the Proliferation of Breast Cancer Cells via Direct Inhibition of c-Myc Gene Expression. | Cells | 2023 | 37508533 | PubTator, text mining | PubMed |
| Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia. | Stem Cell Res Ther | 2023 | 37501071 | PubTator, text mining | PubMed |
| Heterozygous rare variants in NR2F2 cause a recognizable multiple congenital anomaly syndrome with developmental delays. | Eur J Hum Genet | 2023 | 37500725 | PubTator, text mining | PubMed |
| Identification of mammalian transcription factors that bind to inaccessible chromatin. | Nucleic Acids Res | 2023 | 37486787 | PubTator, text mining | PubMed |
| Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum. | Acta Neuropathol | 2023 | 37466726 | PubTator, text mining | PubMed |
| Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis. | Int J Mol Sci | 2023 | 37445988 | PubTator, text mining | PubMed |
| Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development. | Diagnostics (Basel) | 2023 | 37443631 | PubTator, text mining | PubMed |
| An integrated single-cell analysis of human adrenal cortex development. | JCI Insight | 2023 | 37440461 | PubTator, text mining | PubMed |
| Prognostic analysis of lung adenocarcinoma based on cancer-associated fibroblasts genes using scRNA-sequencing. | Aging (Albany NY) | 2023 | 37437244 | PubTator, text mining | PubMed |
| Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells. | Front Immunol | 2023 | 37435067 | PubTator, text mining | PubMed |
| Extracellular matrix cues regulate the differentiation of pluripotent stem cell-derived endothelial cells. | Front Cardiovasc Med | 2023 | 37435057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7026/papers?page=11